Wuhan Zhongzhen Intelligent Co., Ltd. — A flagship project, the “Smart Syringe,” has made a stunning debut.

Release time：2019-12-17

Wuhan Zhongzhen Intelligent Company

“Smart Syringe” Project Report

On December 14, 2019, Mr. Yan Zibao, founder and chairman of Wuhan Zhongke Keli, was invited to present a report on Wuhan Zhongzhen Intelligent Company’s flagship project to a delegation of leaders, including Deputy Minister Li from the United Front Work Department of Wuhan City and Deputy Minister Wan from the Organization Department. “Smart Syringe” , earning unanimous praise and encouragement from everyone!

We are contributing to the emergence of a multi‑billion‑dollar unicorn company in China in the near future, and we are working tirelessly to ensure that smart syringes benefit humanity and shape a brighter future!

Highlights Recap

Product Technical Principles

▼

1. Radiofrequency Microcurrent Detection

Using radiofrequency microcurrent detection, it measures impedance changes in tissues such as fat, muscle, body fluids, blood, and cerebrospinal fluid.

2. Precise detection, flexible configuration

The needle tip can readily and accurately detect the impedance at the injection site or during tissue aspiration, and, through a specialized algorithm or by providing visual cues, it enhances the precision of localization and tissue assessment during these procedures.

3. Impedance Imaging System

The impedance imaging system can be added as needed.

Perform scanning and imaging of the treated area.

4. Case Study Presentation

For example, during injection procedures, it helps prevent complications such as misplacement or embolization and ensures accurate drug delivery; or, during fat‑removal procedures, it enables precise monitoring to avoid harm caused by incorrect aspiration; alternatively, when draining tumor‑related effusions or cerebrospinal fluid, accurate imaging‑guided prediction and precise localization can reduce medical risks and significantly enhance clinicians’ treatment efficiency.

Drawbacks of Traditional Syringes

▼

1. Currently, syringes rely on the clinical experience of healthcare professionals to determine the optimal injection and aspiration sites, which creates a heavy dependence on their expertise. Even highly skilled clinicians often struggle to ensure that the needle consistently reaches the intended target with each procedure.

2. First, in procedures that require aspiration—such as obtaining arterial blood, tumor effusions, cerebrospinal fluid, or draining hematomas and adipose tissue from patients with cardiovascular and cerebrovascular conditions—additional auxiliary equipment is often necessary to complete the task, such as a bedside CT scanner.

3. Furthermore, each year numerous physicians encounter serious medical complications—such as embolism caused by filler material inadvertently entering blood vessels, leading to rapid necrosis of surrounding tissues or thrombosis—due to the inability to prevent such events through current practices. In some cases, targeted drug delivery fails to achieve precise localization, thereby compromising therapeutic outcomes. This is particularly true for injectable anesthetics, where greater precision translates into better efficacy. Smart syringe technology addresses these limitations, providing clinicians worldwide with an intelligent “eye” for injection and aspiration, and offering patients a highly precise tool for treating their lesions.

Project Prospects

▼

1. Output value increased by more than 50 billion.

The market value of the company’s smart syringes is expected to exceed RMB 50 billion.

2. The business model extends downstream.

By bundling hyaluronic acid injections with syringes for sale, output value could double. As related initiatives continue to advance, China is poised to see the emergence of a unicorn enterprise valued at tens or even hundreds of billions of yuan in the near future.

Let us join forces to build a company that benefits humanity! We warmly invite talented individuals with a passion for making a difference to join us.

Highlights Revisited 1

Wuhan Zhongke Keli—Proudly Recognized as One of Wuhan’s Top Ten Model Enterprises for Technological Innovation

Spotlight on the 15th Annual Conference of Chinese Dermatologists | Zhongke Keli Shines Bright!

Wuhan Zhongke Keli—Proudly Recognized as One of Wuhan’s Top Ten Model Enterprises for Technological Innovation

Spotlight on the 15th Annual Conference of Chinese Dermatologists | Zhongke Keli Shines Bright!